Toggle navigation
Home
Search
Services
Blog
Contact
About
Prechronic Toxicity Studies of Carisprodol
Mulligan, Louis T.
Microbiological Associates, Inc., Rockville, MD, United States
Search 62 grants from Louis Mulligan
Search grants from Microbiological Associates, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Understanding the implementation of new practices in health care organizations
A Developmental Model of Gene-Environment Interplay in SUDs
Signaling Mechanisms in Dopamine Receptor Synergism
Longitudinal Studies of Rodent Reservoirs of Hantaviruses in the Sw US
Angiotensinogen Gene Acute Phase Response Element
Recently added grants:
Direct and Indirect Effects of Direct-to-Consumer Advertising
Implementation of a Novel Multi-Platform Evidence-Based Clinical Decision Support System
Title: Consumers United for Evidence-based Healthcare (CUE)
End-of-Life Care for Adolescents and Young Adults with Cancer: An Evaluation of Care and Development of Patient-Centered Quality Measures
Povidone-iodine to Stop Access-related Infections and Transmission of Staphylococcus aureus (PAINTS)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research and Development Contracts (N01)
Project #
N01ES075179-001
Application #
2310694
Study Section
Project Start
1987-03-03
Project End
Budget Start
1987-06-15
Budget End
1988-07-19
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Microbiological Associates, Inc.
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20850
Related projects
NIH 1987
N01 ES
Prechronic Toxicity Studies of Carisprodol
Mulligan, Louis T. / Microbiological Associates, Inc.
NIH 1987
N01 ES
Prechronic Toxicity Studies of Carisprodol
Mulligan, Louis T. / Microbiological Associates, Inc.
Comments
Be the first to comment on Louis Mulligan's grant